The role of cognitive functioning in medication adherence of children and adolescents with HIV infection
- PMID: 18647794
- PMCID: PMC2722123
- DOI: 10.1093/jpepsy/jsn068
The role of cognitive functioning in medication adherence of children and adolescents with HIV infection
Abstract
Objective: To evaluate the relationship between cognitive functioning and medication adherence in children and adolescents with perinatally acquired HIV infection.
Methods: Children and adolescents, ages 3-18 (N = 1,429), received a cognitive evaluation and adherence assessment. Multiple logistic regression models were used to identify associations between adherence and cognitive status, adjusting for potential confounding factors.
Results: Children's average cognitive performance was within the low-average range; 16% of children were cognitively impaired (MDI/FSIQ <70). Cognitive status was not associated with adherence to full medication regimens; however, children with borderline/low average cognitive functioning (IQ 70-84) had increased odds of nonadherence to the protease inhibitor class of antiretroviral therapy. Recent stressful life events and child health characteristics, such as HIV RNA detectability, were significantly associated with nonadherence.
Conclusion: Cognitive status plays a limited role in medication adherence. Child and caregiver psychosocial and health characteristics should inform interventions to support adherence.
References
-
- Bauman LJ, Silver EJ, Draimin BH, Hudis J. Children of mothers with HIV/AIDS: Unmet needs for mental health services. Pediatrics. 2007;120:e1141–e1147. - PubMed
-
- Bayley N. Bayley Scales of Infant Development. 2nd. San Antonio: Psychological Corporation; 1993.
-
- Brown LK, Lourie KJ, Pao M. Children and adolescents living with HIV and AIDS: A review. Journal of Child Psychology and Psychiatry. 2000;41:81–96. - PubMed
-
- Center for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morbidity and Mortality Weekly Report. 1994;43(RR-12):1–10.
-
- Chiriboga CA, Fleishman S, Champion S, Gaye-Robinson L, Abrams EJ. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART) Journal of Pediatrics. 2005;146:402–407. - PubMed
